Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5

por Heinbockel, Lena, Weindl, Günther, Martinez-de-Tejada, Guillermo, Correa, Wilmar, Sanchez-Gomez, Susana, Bárcena-Varela, Sergio, Goldmann, Torsten, Garidel, Patrick, Gutsmann, Thomas, Brandenburg, Klaus
Publicado 2018

Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis

por Heinbockel, Lena, Marwitz, Sebastian, Barcena Varela, Sergio, Ferrer-Espada, Raquel, Reiling, Norbert, Goldmann, Torsten, Gutsmann, Thomas, Mier, Walter, Schürholz, Tobias, Drömann, Daniel, Brandenburg, Klaus, Martinez de Tejada, Guillermo
Publicado 2015

Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbits

por Bárcena-Varela, Sergio, Martínez-de-Tejada, Guillermo, Martin, Lukas, Schuerholz, Tobias, Gil-Royo, Ana Gloria, Fukuoka, Satoshi, Goldmann, Torsten, Droemann, Daniel, Correa, Wilmar, Gutsmann, Thomas, Brandenburg, Klaus, Heinbockel, Lena
Publicado 2017

Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides

por de Tejada, Guillermo Martinez, Heinbockel, Lena, Ferrer-Espada, Raquel, Heine, Holger, Alexander, Christian, Bárcena-Varela, Sergio, Goldmann, Torsten, Correa, Wilmar, Wiesmüller, Karl-Heinz, Gisch, Nicolas, Sánchez-Gómez, Susana, Fukuoka, Satoshi, Schürholz, Tobias, Gutsmann, Thomas, Brandenburg, Klaus
Publicado 2015